Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SpectraWAVE, Inc. logo — Improving coronary artery disease outcomes with optical and...

SpectraWAVE, Inc.

Improving coronary artery disease outcomes with optical and computational insights.

Founded 2017 United States Bedford, United States 56 employees Series B Biotechnology, Health Care +1

General Information

Company Name SpectraWAVE, Inc.
Founded Year 2017
Location United States Bedford, United States
Employees 56
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with SpectraWAVE, Inc.. To contact SpectraWAVE, Inc., visit spectrawave.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SpectraWAVE, Inc. compare?

A PDF of SpectraWAVE, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SpectraWAVE, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SpectraWAVE, Inc.

SpectraWAVE, located in Bedford, Mass., is a privately held medical device company founded in 2017 to provide unrivaled optical and computational insights to improve the treatment and outcomes for patients with coronary artery disease (CAD). CAD, the buildup of plaque in the wall of the arteries that supply blood to the heart, affects 18.2 million adults age 20 and older. In CAD patients that undergo percutaneous stent placement, it is estimated that one in five patients experience adverse events within two years. SpectraWAVE’s state of the art HyperVue™ Imaging System combines next generation DeepOCT™ images and near infrared spectroscopy (NIRS) with workflows optimized for the cardiac catheterization lab. The HyperVue Imaging System is intended for the imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. The NIRS capability of the system is intended for the identification of patients and plaques at increased risk of major adverse cardiac events. For more information and complete indications for use, please visit www.spectrawave.com.

Business keywords: medical device development, cardiovascular disease, optical and computational technology, coronary artery disease, DeepOCT, near infrared spectroscopy, diagnostic equipment, therapeutic devices, interventional cardiology, cardiac catheterization, patient outcomes, transluminal interventional procedures

No funding data available for SpectraWAVE, Inc. yet.

SpectraWAVE, Inc. Alternatives & Competitors

View All Alternatives
SpectraWAVE, Inc. vs
Kaminari Medical
Kaminari Medical The Netherlands

Combining ultrasound and optical imaging to revolutionize coronary revascularization

Seed
10 employees
Health Care, Medical Devices
Compare SpectraWAVE, Inc. vs Kaminari Medical
SpectraWAVE, Inc. vs
Roxwood Medical
Roxwood Medical

Innovative solutions for advanced cardiovascular specialty catheters in Interventional Cardiology, E...

Venture round
Health Care, Medical Devices
SpectraWAVE, Inc. vs
AngioScore
AngioScore United States

The AngioSculpt Scoring Balloon Catheter significantly alters the landscape for treating both periph...

Venture round
56 employees
Biotechnology, Health Care
Also compare with: SpectraWAVE, Inc. vs CathWorks CathWorks View all alternatives

FAQ About SpectraWAVE, Inc.

Improving coronary artery disease outcomes with optical and computational insights.
SpectraWAVE, Inc. was founded in 2017.
SpectraWAVE, Inc. is headquartered in Bedford, United States.
SpectraWAVE, Inc. operates in Biotechnology, Health Care and Medical Devices. Its work centres on medical device development, cardiovascular disease, optical and computational technology and coronary artery disease.
SpectraWAVE, Inc. has approximately 56 employees.
Top alternatives and competitors to SpectraWAVE, Inc. include Kaminari Medical, Roxwood Medical, AngioScore, Miracor Medical SA, Arstasis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SpectraWAVE, Inc. and Kaminari Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SpectraWAVE, Inc., https://bouncewatch.com/company/spectrawave-inc, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes